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The activation of N-methyl D-aspartate receptors is conditioned by the binding of a co-agonist to a 
dedicated receptor binding site. It is now largely accepted that D-serine plays this role at many central 
synapses in the hippocampus, amygdala, hypothalamus, nucleus accumbens, and in the prefrontal, 
visual and somatosensory cortices.  D-serine has been found to be synthesized, stored and released by 
astrocytes (Figure 1). Yet, several immuno-labeling studies and experiments in genetically modified 
animals have recently led to a suggestion that neurons are primarily responsible for the synthesis and 
release of D-serine (Wolosker et al. 2016). Here, we argue that such conclusions could have resulted 
from the erroneous interpretation of experimental data and that they are at odds with a substantial 
amount of published work. 
 
The existence of gliotransmission is not under debate 
The proponents of the neuronal-only D-serine hypothesis argue that the entire process of 
gliotransmission is under question, referring to a study that reported no causal link between IP3R2 
receptor-dependent Ca2+ signals in astroglia and synaptic function (Agulhon, 2010). That study assumed 
that gliotransmission relies entirely on IP3R2-dependent Ca2+ signaling. Therefore its results suggested a 
flaw in such underlying assumption, rather than a disproof of gliotransmission. Consistently, improved 
imaging methods have since then revealed that, even under genetic deletion of IP3R2, Ca2+-signaling 
occurs in thin astroglial processes (Srinivasan et al., 2015). 
 
Robust evidence supports the astrocytic origin of D-serine  
The astroglial origin of D-serine has been established by several independent groups using 
complementary techniques, including its detection using electron microscopy (Bergersen et al., 2011, 
Figure 1A; Takata et al. 2011; Sultan et al., 2016, Figure 1C; Henneberger et al. 2011, Figure 1D; 
Martineau et al., 2013, Figure 1E). Together, these studies have proposed that D-serine is synthesized in 
astrocytes, stored in vesicles and released via calcium-dependent exocytosis, in vitro and in vivo. 
Furthermore, enzymology evidence suggests that the optimal conditions exist for D-serine synthesis in 
astrocytes (Ehmsen et al., 2013) and D-serine degradation in neurons (Foltyn et al., 2005). Taken 
together, these data support the concept that D-serine originates from astrocytes, acts at synaptic 
NMDARs and is taken up by neurons where it is degraded (Figure 1F). To our knowledge, there has been 
no systematic criticism or controversy in the literature that could brand these results as “artifacts” or 
ignore them altogether (Wolosker et al. 2016).  
 
The 'three pillars' of the neuronal hypothesis: fact checking 
What does D-serine and serine racemase detection in neurons really mean? 
Wolosker et al. argue that the presence of strong immuno-labeling for D-serine and its synthesizing 
enzyme serine racemase (SR) in neurons, rather than in glia (Wolosker et al. 2016), provides compelling 
evidence that D-serine is synthetized by neurons rather than astrocytes. However, astrocytic processes 
only account for 5-7% of the neuropil volume while neuronal elements make up 70-75% of it, partly 
because the surface-to-volume ratio of astrocytes (~25µm-1) is 3-4-fold that of neurons (~7µm-1) in 
hippocampal neuropil (Medvedev et al., 2014 and references therein). This means that, for similar 
cellular expression of D-serine or SR, the staining for D-serine and SR would appear 10 times stronger in 
neurons than in astroglia. These simple considerations illustrate the difficulties of translating tissue 
immuno-labelling of D-serine and SR into the predictions of their cellular abundance, or into conclusions 
on the cellular origin of D-serine.  
Another caveat in the interpretation of immunostaining data (Wolosker et al. 2016) is to consider SR 
solely as a D-serine synthesizing enzyme. Indeed, SR is bidirectional and bifunctional: it can use either D-
serine or L-serine as substrates, with similar affinities, and can degrade D-serine through α,β-elimination 
(Foltyn et al., 2005); resulting in a complex picture. In fact, enzymatic studies showed that under 
physiological conditions, the presence of D-serine and SR at high levels in the same cellular 
compartment favors the degradation activity of SR over racemization (Foltyn et al., 2005). Therefore, the 
suggested abundance of SR and D-serine in neurons might actually argue that neurons are a degradation 
compartment for D-serine. 
To date, there has been no D-serine release machinery identified in neurons 
An important argument of the neuronal D-serine hypothesis is the presumed existence of a dedicated 
transport system. The idea that a “large fraction of D-serine release occurs by the neuronal Asc-1 
transporter” (Wolosker et al. 2016) is based on studies that used various Asc-1 substrates to “artificially 
increase the rate of D-serine release” from D-serine-preloaded neurons or slices (see Rosenberg et al., 
2013). But careful examination of these studies leads to the conclusion that, in the absence of 
manipulation, Asc-1 is involved in D-serine uptake by neurons, not efflux. Indeed, Asc-1 mediates a 
bidirectional transport and the net flux of D-serine can easily be manipulated. The cited studies used D-
Ile, a substrate of Asc-1 that blocks D-serine uptake and favors its release via D-serine/D-Ile exchange. 
Consequently, while the authors observed a strong D-serine uptake by neuronal Asc-1 without D-Ile, 
they detected a rise in D-serine levels when D-Ile is applied to brain slices or neuronal cultures 
preloaded with D-serine (Rosenberg et al., 2013). The logical conclusion is that, under physiological 
conditions, D-serine is taken up by neuronal Asc-1 which, in the presence of D-Ile, can be artificially 
reversed into a D-serine efflux. Besides, the adult mice lacking the Asc-1 gene have unaltered D-serine 
levels (Safory, 2015), thus ruling out a role of this transporter in the supply of extracellular D-serine. 
Therefore, since ASCT-1 and ASCT-2 are unfit to transport D-serine (EC50 ~1.1-1.8mM), and since no D-
serine vesicular transporter is known in neurons (Martineau et al., 2013), there is, to date, no conclusive 
evidence that neurons can release D-serine under physiological conditions.  
 
Knock-out studies are inconclusive  
The last argument in support of the neuronal view comes from a study that used cell-specific and 
conditional SR knock-outs (KOs) (Benneyworth et al., 2012) and concluded that the deletion of SR in 
neurons (nSR-KO) impairs D-serine availability while the deletion in astrocytes (aSR-KO) does not. 
Unfortunately, this conclusion is affected by the fact that D-serine levels were examined at very 
different time-points: 4-10 weeks in nSR-KOs, but 10-15 days aSR-KOs. In addition, whether SR protein is 
completely obliterated in astrocytes 10-15 days after the deletion of SR gene (Srr), and whether D-serine 
stores are truly depleted, is unclear. Therefore, assessing D-serine levels 10-15 days after deletion of Srr 
in astrocytes is unlikely to reveal a significant reduction of D-serine content (Benneyworth et al., 2012). 
Intriguingly, even though the D-serine levels were examined at a much later time-point in the neuronal 
KO, the study found that these levels were also intact in the hippocampus of nSR-KOs. However, 
because a modest reduction was detected in the cortex (exclusively) of 12-week old nSR-KOs, it was 
concluded that D-serine is produced in neurons. This is an unsafe conclusion at best in light of the 
experimental design issues mentioned above. Furthermore, the recombination induced in the nSR-KOs 
occurs around postnatal day 15, a time when the levels of SR protein and D-serine are still a fraction of 
those found in adults (Wang & Zhu, 2003). Therefore, deleting Srr in neurons at this critical time should 
have had early and strong effects on D-serine levels, unless of course, neurons are not a site of D-serine 
production.  
 
Concluding remarks: 
The experimental evidence for the presence of D-serine and SR in neurons is not to be dismissed, and 
efforts should be made to integrate it into our understanding and conceptualization of D-serine 
physiology (Figure 1F). Nonetheless, there is, to date, no consistent evidence indicating that neurons are 
a major source of extracellular D-serine, and therefore the astroglial origin of D-serine remains the best 
working model.  
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Figure Legend: 
A, Using electron microscopy, D-serine is found in peri-synaptic astrocytic processes inside of, or in close 
association with, synaptic-like micro-vesicles (SLMVs). Note that D-serine is also found in the cytoplasm 
of neuronal elements, but not in vesicles (adapted from Bergersen et al., 2011. Glutamate transporter 
EAAT2 is labeled with large immuno-gold particles. D-serine is labeled with small immuno-gold particles. 
Ast: astrocytic process; Sp: dendritic spine; Term: presynaptic terminal.) B, Similarly, in astrocytes in 
vitro, D-serine is found in VAMP2 (synaptobrevin)-containing SLMVs that are recruited to the plasma 
membrane upon calcium stimulation (adapted from Martineau et al., 2008. D-serine is labeled in red 
and VAMP2 in green (eGFP-Sb2). n: nucleus). C1-C3, Consistently, the blockade of vesicular release with 
botulinum toxin or with transgenic inhibition of the SNARE-complex (dnSNARE mice) as well as the 
blockade of calcium activity in astrocytes, impairs extracellular D-serine availability in vitro and in vivo 
(Henneberger et al. 2011, Takata et al. 2011, Sultan et al., 2016). For instance, in GFAP-tTA:tetO-
dnSNARE mice and iBot-Glast-CreERT2 mice, a dominant negative form of VAMP2 or the botulinum 
toxin (that cleaves endogenous VAMP2) are selectively expressed in astrocytes (C1), resulting in a 90% 
decrease in the total number of vesicular fusion events assessed by TIRF illumination (C2). 
Concomitantly, the levels of D-serine, assessed in slices using high performance liquid chromatography, 
are impaired by 50% (adapted from Sultan et al., 2016. dnSNARE – Dox: dnSNARE mouse off doxycycline, 
iBot-Glast + Tam:  iBot-Glast-CreERT2 mouse treated with tamoxifen, green: transgene-expressing 
astrocytes, Red: RFP-expressing principal neuron of the dentate gyrus, Blue: Dapi staining). D1-D3, 
When astrocytes from a hippocampal slice are loaded with a “Ca2+ clamp” solution through a patch-
pipette to maintain Ca2+ levels at resting concentrations (D1), NMDAR-mediated responses recorded in 
the corresponding territory are rapidly impaired (D2). This can be either prevented or blocked by D-
serine applications. Consequently, synaptic plasticity induced with a classic protocol is prevented in the 
territory of a Ca2+-clamped astrocyte due to the lack of D-serine (D3). Therefore, functionally preventing 
the Ca2+-dependent vesicular release from one astrocyte directly impairs D-serine availability at nearby 
synapses (adapted from Henneberger et al., 2011. IP, intracellular patch-pipette; EP, extracellular 
pipette; BV: blood vessel). E1-E2, The exocytotic route of D-serine release by astrocytes received further 
confirmation through the identification of a D-serine specific vesicular transporter (vSerT) on astrocyte 
SLMVs, responsible for loading D-serine into vesicles (E1). The loading of D-serine, in the presence of 
ATP (required for creating a proton gradient by the vesicular ATPase), can be seen as an acidification of 
the vesicle in photometry experiments (E2). Interestingly, in astrocytes, SR was found directly bound to 
VAMP2-containing SLMVs (E1). Consistently, L-serine elicits a vesicular acidification similar to D-serine. 
However, when SR activity is inhibited with hydroxy-aspartate (HOAsp, E2) the effect of L-serine on 
vesicular acidification is prevented, while D-serine loading is unaltered (adapted from Martineau et al., 
2013. (NH4)2SO4 is applied at the end of the experiment to dissipate vesicular gradient; scale: 2 arbitrary 
units per 1 min). F, Current working model: in astrocytes, D-serine is readily stored in vesicles upon 
synthesis (protecting newly synthesized D-serine from α,β-elimination by SR). Interestingly, the D-serine 
precursor L-serine does not cross the blood brain barrier, and the only known L-serine production 
pathway in the brain parenchyma occurs via 3-Phosphoglycerate Dehydrogenase (Phgdh), an enzyme 
exclusively found in astrocytes (Ehmsen et al., 2013). Consequently, in astrocytes cytoplasm, SR is facing 
high and constant levels of L-serine but virtually no D-serine, strongly favoring the racemization activity 
of L-serine into D-serine. As explained in the main text, once released in a Ca2+ and SNARE-dependent 
manner, D-serine is likely taken up by neurons (through Asc-1?) where it accumulates (hence its 
detection in neurons) and is degraded by SR through racemization or α,β-elimination.  
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